Skip to content

ORTHOBILITY

Active
Public limited companyfounded 20196 years activeVlamingveld 15, 8490 Jabbeke, BelgiumKBO/BCE: BE 0737.985.403
Summary

ORTHOBILITY has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.3m and a net result of €727,909. Equity is growing by ~30.5% per year across the filed fiscal years. Its solvency ranks better than 74% of 4,935 sector peers (NACE 47, fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
NACE 47741Manufacture of medical and dental instruments and supplies NACE 32500
#5 employer in Jabbeke, Wholesale and retail trade sector1 site
Size
€2.2mtotal assets 2025
Staff
10.5 FTE
Equity
€1.3m
Profit
€727,909
Net result +86%: other schema
Financial health
96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
  • BV DesafkaDirector · permanent representative Luc Defoort
  • BV OrthonexisManaging director · permanent representative Vanessa Wouters
  • CommV LocavinoDirector · permanent representative Jelle Accou
Accounts 49 days early1 of 4 deeds read
Why 96+ Liquidity: current ratio 2.26, cash €577,859+ Equity €1.3m (60.5% of total assets)+ Figures for FY 2025 (filed 12-06-2026)+ Profit of €727,909 (FY 2025)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 75% of its sector peers (NACE 47, small)
Financial strength · tick = 2024
Strong
Solvency 85-8
equity 60.5% of total assets
Liquidity 67+7
short-term debt 35.2% · cash 26.1%
Profitability 100+7
return on assets 32.9%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (3,689 companies)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.3%▲ +0.1 percentage points vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.3%● unchanged vs 06-2025highest value 08-2025: 0.2%▼ -0.1 percentage points vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.1%▼ -0.1 percentage points vs 06-2026lowest value 08-2026: 0.1%● unchanged vs 07-2026lowest value 09-2026: 0.1%● unchanged vs 08-2026lowest value 10-2026: 0.1%● unchanged vs 09-2026
Credit up to €120,000 at 30 days acceptable
Liquidity ample (current ratio 2.26 against 3.35 in 2024; short-term debt: 35.2% and cash: 26.1% of total assets), and 39.5% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, small): better than 81% on solvency, 87% on liquidity, 98% on profitability and 33% on growth.

The bankruptcy probability was computed on 08-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk○neutral
lowers risk · Liquidity: current ratio 2.26, cash €577,859
NBB · annual accounts
lowers risk · Equity €1.3m (60.5% of total assets)
NBB · annual accounts
lowers risk · Figures for FY 2025 (filed 12-06-2026)
NBB · annual accounts
lowers risk · Profit of €727,909 (FY 2025)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-06-2026, 49 days ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2025
49 days early
2024
34 days early
2023
40 days early
2022
45 days early
2021
52 days early
2020
71 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 49 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 16 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
08-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · full…
  2. Highest result since 2020net €727,909 ▲86%
  3. Appointments: BV ORTHONEXIS (non-statutory director) and…Permanent representatives: Vanessa Wouters, Luc…

Key points

  • Positive: Staff rose in 2025different schema filed ▲ 98.1% View
  • Caution: Board changedlatest change 26-11-2025 · 3 in office 3 joined · 3 left View
  • Positive: Among the best 9% on net resultsector median €40,857 · 4,935 companies €727,909 View
  • Positive: Always filed on timeaccounts within the deadline every year 6 years View
  • Positive: 6 profitable years in a rowprofit 2025: €727,909 6 years View

By topic

Financials

Fiscal year
2025
Total assets
€2.2m
Profit
€727,909
Solvency
60.5%
Total assets▲ 11.1%
Net result
20202025
Go to Financials

Board & ownership

Board
3 members
  • BV DesafkaDirector
  • BV OrthonexisManaging director
  • CommV LocavinoDirector
Go to Board & ownership

Timeline

Events
11
Since
2021
Next accounts
by 31-07-2027
  1. 27-06-2025Annual accounts filed
  2. 31-12-2024Equity above €1m
  3. 21-06-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Retail sale of medical and orthopaedic goods, excluding…NACE 47741
Founded
22-11-2019
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.